Research & Development
Cordis releases 2-year data from Incraft stent trial
Cordis Corp, a Johnson & Johnson (NYSE:JNJ) subsidiary, released 2-year data from its INNOVATION trial testing the safety and performance of the Incraft abdominal aortic aneurysm stent graft system.
Boston Scientific donates $3.4M to Saint Luke’s cardiac research | MassDevice.com On Call
MASSDEVICE ON CALL — Massachusetts medtech giant Boston Scientific (NYSE:BSX) awarded a $3.4 million 3-year grant to support cardiac research at Saint Luke’s Mid America Heart Institute.
Report: FDA looks for more women in medtech trials | MassDevice.com On Call
MASSDEVICE ON CALL — Based on the results of a newly unveiled study, the FDA plans to implement new processes to ensure that women make up an appropriate portion of medical device post-approval studies.
Smith & Nephew touts positive results for wound therapy
Study: Hip implant regulatory review ‘entirely inadequate’
A group of U.K. researchers is calling for a major shift in regulation of orthopedic hip implants, warning that a significant number of the devices get on the market without providing much evidence of their safety or efficacy.
Another robot surgery study shows reduced complications, readmissions over open surgery
Drug-eluting stent patients may cut down post-procedure blood-thinners, study says
Patients getting drug-eluting stents may be able to cut their post-procedure blood thinner regimen by as much as 75%, according to study published this week in the Journal of the American Medical Assn.
Medtronic’s new renal denervation trial examines less-severe hypertension
Study: Medtronic’s Prestige spinal disc replacement beats fusion in 7-year results
EnteroMedics releases positive results from VBLOC pivotal trial
EnteroMedics (NSDQ:ETRM) revealed results for the 1st 18 months of its 5-year ReCharge pivotal trial for its VBLOC therapy, an implanted neurostimulator designed to help prevent obesity.